Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
NaxSwab™ OTC Novel Naloxone Nasal Swab is an opioid antagonist that acts by blocking the effects of opioids at the opioid receptors. It is used in emergency rescue environment to potentially revive someone from an opioid overdose.
Lead Product(s): Naloxone Hydrochloride
Therapeutic Area: Psychiatry/Psychology Product Name: NaxSwab
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable April 13, 2023
Details:
Naloxone is an opioid antagonist that acts by blocking the effects of opioids at the opioid receptors. Pharmacokinetic study data shows NaxSwab OTC has 74% and 1096% higher exposures at 2.5 minutes compared to naloxone HCI 4mg nasal spray and 0.4mg IM naloxone injection.
Lead Product(s): Naloxone Hydrochloride
Therapeutic Area: Psychiatry/Psychology Product Name: NaxSwab
Highest Development Status: Phase IProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable December 01, 2022